These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 14581723)

  • 1. Proximal tubule damage in patients treated with gentamicin or amikacin.
    Wiland P; Szechciński J
    Pol J Pharmacol; 2003; 55(4):631-7. PubMed ID: 14581723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymuria determination in children treated with aminoglycosides drugs.
    Mohammadi-Karakani A; Asgharzadeh-Haghighi S; Ghazi-Khansari M; Seyed-Ebrahimi A; Ghasemi A; Jabari E
    Hum Exp Toxicol; 2008 Dec; 27(12):879-82. PubMed ID: 19273542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An early and specific indicator of aminoglycoside nephrotoxicity: isoenzyme B of urinary N-acetyl-beta-D-glucosaminidase (NAG)].
    Gibey R; Dupond JL; Peltier H; Iehl-Robert M; Henry JC
    Pathol Biol (Paris); 1986 May; 34(5):342-5. PubMed ID: 3534703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.
    Etherington C; Bosomworth M; Clifton I; Peckham DG; Conway SP
    J Cyst Fibros; 2007 Jan; 6(1):67-73. PubMed ID: 16844430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
    Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
    J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective comparative study of gentamicin- and amikacin-induced nephrotoxicity in patients with normal baseline renal function.
    Sweileh WM
    Fundam Clin Pharmacol; 2009 Aug; 23(4):515-20. PubMed ID: 19709328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of urinary N-acetyl-beta-D-glucosaminidase activity in patients receiving aminoglycoside and cephalosporin drugs.
    Naruse T; Hirokawa N; Oike S; Maekawa T
    Res Commun Chem Pathol Pharmacol; 1981 Feb; 31(2):313-29. PubMed ID: 7221185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted prevention of renal accumulation and toxicity of gentamicin by aminoglycoside binding receptor antagonists.
    Watanabe A; Nagai J; Adachi Y; Katsube T; Kitahara Y; Murakami T; Takano M
    J Control Release; 2004 Mar; 95(3):423-33. PubMed ID: 15023454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nephrotoxicity of the combination of cyclosporin and aminoglycoside in rats. Comparative study of gentamicin and amikacin].
    Gibey R; Mozer JL; Henry JC
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):513-6. PubMed ID: 2385448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of selected indicators of the renal proximal tubule function in patients treated with gentamicin].
    Pupek-Musialik D
    Pol Tyg Lek; 1992 Aug 7-17; 47(31-33):676-9. PubMed ID: 1492034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of gentamicin, amikacin and dactimicin on excretion of N-acetyl-beta-D-glucosaminidase (NAG) and kidney histological pattern in rats.
    Palla R; Paternoster G; Galigani P; Giovannini L; Bertelli AA; Romano MR; Alessandrì MG; Bertelli A
    Drugs Exp Clin Res; 1987; 13(12):751-6. PubMed ID: 3447879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the structure and function of the kidney of rats chronically exposed to cadmium. I. Biochemical and histopathological studies.
    Brzóska MM; Kamiński M; Supernak-Bobko D; Zwierz K; Moniuszko-Jakoniuk J
    Arch Toxicol; 2003 Jun; 77(6):344-52. PubMed ID: 12799774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urinary excretion of phospholipids: index of aminoglycoside nephrotoxicity].
    Olier B; Borsa F; Morin JP; Humbert G; Fillastre JP
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):577-81. PubMed ID: 3534746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetyl-beta-D-glucosaminidase enzymuria as an indicator in monitoring the therapy of some rheumatic diseases with potentially nephrotoxic drugs.
    Wiland P; Szechiński J
    Arch Immunol Ther Exp (Warsz); 1994; 42(4):331-6. PubMed ID: 7487376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Excretion of N-acetyl-beta-D-glucosaminidase in the urine of children with type I juvenile diabetes mellitus and of patients treated with the aminoglycoside amikacin].
    Wiesmann U; Peheim E; Colombo JP
    Klin Wochenschr; 1989; 67 Suppl 17():40-3. PubMed ID: 2739356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once daily isepamicin treatment in complicated urinary tract infections.
    Lee SS; Liu YC; Wann SR; Lin WR; Tsai TH; Lin HH; Chen YS; Yen MY
    J Microbiol Immunol Infect; 1999 Jun; 32(2):105-10. PubMed ID: 11561574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney graft function in long-term cyclosporine and tacrolimus treatment: comparative study with nephrotoxicity markers.
    Marchewka Z; Kuźniar J; Zynek-Litwin M; Falkiewicz K; Szymańska B; Roszkowska A; Klinger M
    Transplant Proc; 2009 Jun; 41(5):1660-5. PubMed ID: 19545703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute gentamicin-induced hypercalciuria and hypermagnesiuria in the rat: dose-response relationship and role of renal tubular injury.
    Parsons PP; Garland HO; Harpur ES; Old S
    Br J Pharmacol; 1997 Oct; 122(3):570-6. PubMed ID: 9351517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrotoxicity induced by gentamicin and amikacin.
    Smith CR; Maxwell RR; Edwards CQ; Rogers JF; Lietman PS
    Johns Hopkins Med J; 1978 Mar; 142(3):85-90. PubMed ID: 342789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relation of enzyme distribution in the kidney and increase pattern of urinary N-acetyl-beta-D-glucosaminidase (NAG) and gamma-glutamyl transpeptidase (gamma-GTP) activities following CDDP administration].
    Takahashi T; Yoshida K; Nakame Y; Saitoh H
    Hinyokika Kiyo; 1987 Oct; 33(10):1569-74. PubMed ID: 2895573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.